We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$49.9M
(+0.3%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
1,532
New
77
Increased
144
Reduced
521
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$139M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$38M |
| 3 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$34.7M |
| 4 |
Sonida Senior Living
SNDA
|
+$25.5M |
| 5 |
Theravance Biopharma
TBPH
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$68M |
| 2 |
ConocoPhillips
COP
|
+$44.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$35.7M |
| 4 |
Zimmer Biomet
ZBH
|
+$33.7M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 12.64% |
| 3 | Industrials | 9.32% |
| 4 | Technology | 8.7% |
| 5 | Consumer Staples | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Aon
AON
$76B
| $18.2M | 0.11% |
162,989
-24,119
| -13% | -$2.69M |
|
127
Ardelyx
ARDX
$1.27B
| $17.3M | 0.11% |
1,221,128
+167,500
| +16% | +$2.38M |
|
|
CSII
128
DELISTED
Cardiovascular Systems, Inc.
CSII
| $17.1M | 0.1% |
707,500
-56,700
| -7% | -$1.39M |
|
129
Kimberly-Clark
KMB
$35.6B
| $16.8M | 0.1% |
146,918
-323
| -0.2% | -$37.5K |
|
130
PepsiCo
PEP
$184B
| $16.8M | 0.1% |
160,182
+3,841
| +2% | +$402K |
|
|
CELG
131
DELISTED
Celgene Corp
CELG
| $16.2M | 0.1% |
140,295
-3,853
| -3% | -$429K |
|
132
Enanta Pharmaceuticals
ENTA
$377M
| $16.2M | 0.1% |
484,500
+311,200
| +180% | +$8.92M |
|
133
Amdocs
DOX
$5.4B
| $16.1M | 0.1% |
277,233
-2,538
| -0.9% | -$150K |
|
134
Graco
GGG
$12.6B
| $15.8M | 0.1% |
571,608
| – | – |
|
135
Intercontinental Exchange
ICE
$81B
| $15.8M | 0.1% |
279,970
-19,920
| -7% | -$1.1M |
|
|
LSXMA
136
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $15.5M | 0.09% |
620,743
-1,663
| -0.3% | -$41.4K |
|
137
Loews
L
$23.8B
| $15.3M | 0.09% |
327,767
-25,631
| -7% | -$1.12M |
|
138
Brookfield Renewable
BEP
$10B
| $15.1M | 0.09% |
956,593
+22,518
| +2% | +$354K |
|
139
Cisco
CSCO
$444B
| $15.1M | 0.09% |
500,628
+706
| +0.1% | +$21.5K |
|
|
BECN
140
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $15M | 0.09% |
324,783
-927
| -0.3% | -$41.4K |
|
|
DNKN
141
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $14.8M | 0.09% |
282,277
+281,804
| +59,578% | +$14.5M |
|
|
HTO
142
H2O America
HTO
$2.67B
| $14.6M | 0.09% |
260,650
-2,260
| -0.9% | -$114K |
|
143
Titan International
TWI
$508M
| $14.3M | 0.09% |
1,278,101
-149,000
| -10% | -$1.63M |
|
144
Colgate-Palmolive
CL
$72.1B
| $14.2M | 0.09% |
216,281
-13,542
| -6% | -$929K |
|
145
JPMorgan Chase
JPM
$930B
| $14M | 0.09% |
162,268
-17,642
| -10% | -$1.35M |
|
146
Merck
MRK
$322B
| $14M | 0.08% |
248,656
-6,462
| -3% | -$378K |
|
147
Middlesex Water
MSEX
$1.05B
| $13.9M | 0.08% |
324,597
-7,400
| -2% | -$284K |
|
|
VRE
148
DELISTED
Veris Residential
VRE
| $13.6M | 0.08% |
468,859
+13,290
| +3% | +$356K |
|
149
Capital Southwest
CSWC
$1.46B
| $13.4M | 0.08% |
826,727
-15,359
| -2% | -$228K |
|
150
Sempra
SRE
$61.1B
| $12.9M | 0.08% |
255,476
-1,910
| -0.7% | -$97.2K |
|
Similar funds
SAM
First Manhattan's Q4 2016 Portfolio in Review
As of Q4 2016, First Manhattan held 1,532 positions worth $16.4B, up 0.3% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q4 2016 filing shows 77 new, 144 increased, 521 reduced and 96 closed positions. Its largest new stake was Coty: 6,723,666 shares worth $123M. The largest sale was Allergan plc, an estimated $68M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2016 buy was Coty: 6,723,666 shares worth $123M.
- First Manhattan added most to Teva Pharmaceuticals in Q4 2016, an estimated $38M increase.
- First Manhattan's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $68M.
- First Manhattan fully exited Starz - Series A in Q4 2016, selling an estimated $2.9M.
- First Manhattan's ten largest holdings make up 44% of its $16.4B portfolio in Q4 2016.
- First Manhattan opened 77 new positions and closed 96 in Q4 2016.
- First Manhattan's portfolio value rose 0.3% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.